Terms: = Brain cancer AND KIAA1549, ENSG00000122778, 57670 AND Treatment
46 results:
1. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.
Nahar Metu CL; Sutihar SK; Sohel M; Zohora F; Hasan A; Miah MT; Rani Kar T; Hossain MA; Rahman MH
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1889. PubMed ID: 37675821
[TBL] [Abstract] [Full Text] [Related]
2. Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis.
Santino SF; Salles D; Stávale JN; Malinverni ACM
Pathol Res Pract; 2023 Aug; 248():154593. PubMed ID: 37331182
[TBL] [Abstract] [Full Text] [Related]
3. LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
Hardin EC; Schmid S; Sommerkamp A; Bodden C; Heipertz AE; Sievers P; Wittmann A; Milde T; Pfister SM; von Deimling A; Horn S; Herz NA; Simon M; Perera AA; Azizi A; Cruz O; Curry S; Van Damme A; Garami M; Hargrave D; Kattamis A; Kotnik BF; Lähteenmäki P; Scheinemann K; Schouten-van Meeteren AYN; Sehested A; Viscardi E; Wormdal OM; Zapotocky M; Ziegler DS; Koch A; Hernáiz Driever P; Witt O; Capper D; Sahm F; Jones DTW; van Tilburg CM
Neuro Oncol; 2023 Nov; 25(11):2087-2097. PubMed ID: 37075810
[TBL] [Abstract] [Full Text] [Related]
4. The clinical and molecular characteristics of progressive hypothalamic/optic pathway pilocytic astrocytoma.
Li X; Moreira DC; Bag AK; Qaddoumi I; Acharya S; Chiang J
Neuro Oncol; 2023 Apr; 25(4):750-760. PubMed ID: 36260562
[TBL] [Abstract] [Full Text] [Related]
5. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.
Misove A; Vicha A; Broz P; Vanova K; Sumerauer D; Stolova L; Sramkova L; Koblizek M; Zamecnik J; Kyncl M; Holubova Z; Liby P; Taborsky J; Benes V; Pernikova I; Jones DTW; Sill M; Stancokova T; Krskova L; Zapotocky M
Acta Neuropathol Commun; 2022 Sep; 10(1):143. PubMed ID: 36163281
[TBL] [Abstract] [Full Text] [Related]
6. Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling.
Anastasaki C; Chatterjee J; Cobb O; Sanapala S; Scheaffer SM; De Andrade Costa A; Wilson AF; Kernan CM; Zafar AH; Ge X; Garbow JR; Rodriguez FJ; Gutmann DH
Acta Neuropathol Commun; 2022 Aug; 10(1):120. PubMed ID: 35986378
[TBL] [Abstract] [Full Text] [Related]
7. Diffuse leptomeningeal glioneuronal tumor in an 8-year-old girl: case report and review of the literature.
Cambruzzi E; Medeiros MS; Cardoso CE; Silva GAG; Schlotte K; Kus WP
Childs Nerv Syst; 2023 Jan; 39(1):301-305. PubMed ID: 35922601
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E brain Tumor Models.
Li F; Bondra KM; Ghilu S; Studebaker A; Liu Q; Michalek JE; Kogiso M; Li XN; Kalapurakal JA; James CD; Burma S; Kurmasheva RT; Houghton PJ
Clin Cancer Res; 2022 Sep; 28(17):3836-3849. PubMed ID: 35797217
[TBL] [Abstract] [Full Text] [Related]
9. Single-agent Bevacizumab in the treatment of Symptomatic Newly Diagnosed and Recurrent/Refractory Pediatric Cervicomedullary brainstem Low-grade Gliomas: A Single Institutional Experience.
Sridhar S; Paul MR; Yeh-Nayre L; Khanna PC; Elster J; Aristizabal P; Crawford JR
J Pediatr Hematol Oncol; 2023 Jan; 45(1):e21-e25. PubMed ID: 35426868
[TBL] [Abstract] [Full Text] [Related]
10. Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience.
Colli SL; Cardoso N; Massone CA; Cores M; García Lombardi M; De Matteo EN; Lorenzetti MA; Preciado MV
PLoS One; 2022; 17(4):e0266466. PubMed ID: 35363819
[TBL] [Abstract] [Full Text] [Related]
11. The involvement of the MAPK pathway in pilocytic astrocytomas.
Salles D; Santino SF; Ribeiro DA; Malinverni ACM; Stávale JN
Pathol Res Pract; 2022 Apr; 232():153821. PubMed ID: 35231859
[TBL] [Abstract] [Full Text] [Related]
12. ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric brain Tumor Consortium.
Vajapeyam S; Brown D; Ziaei A; Wu S; Vezina G; Stern JS; Panigrahy A; Patay Z; Tamrazi B; Jones JY; Haque SS; Enterline DS; Cha S; Jones BV; Yeom KW; Onar-Thomas A; Dunkel IJ; Fouladi M; Fangusaro JR; Poussaint TY
AJNR Am J Neuroradiol; 2022 Mar; 43(3):455-461. PubMed ID: 35210278
[TBL] [Abstract] [Full Text] [Related]
13. Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification / characterisation of low grade glioneuronal tumours.
Dyke J; Calapre L; Beasley A; Gray E; Allcock R; Bentel J
Pathol Res Pract; 2022 Jan; 229():153724. PubMed ID: 34942511
[TBL] [Abstract] [Full Text] [Related]
14. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract] [Full Text] [Related]
15. [Pediatric Glioma].
Terashima K; Ogiwara H
No Shinkei Geka; 2021 May; 49(3):640-646. PubMed ID: 34092570
[TBL] [Abstract] [Full Text] [Related]
16. Radiohistogenomics of pediatric low-grade neuroepithelial tumors.
Bag AK; Chiang J; Patay Z
Neuroradiology; 2021 Aug; 63(8):1185-1213. PubMed ID: 33779771
[TBL] [Abstract] [Full Text] [Related]
17. High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group.
Perwein T; Benesch M; Kandels D; Pietsch T; Schmidt R; Quehenberger F; Bison B; Warmuth-Metz M; Timmermann B; Krauss J; Thomale UW; Kortmann RD; Driever PH; Gnekow AK
Neuro Oncol; 2021 Jul; 23(7):1148-1162. PubMed ID: 33346834
[TBL] [Abstract] [Full Text] [Related]
18. Response to trametinib treatment in progressive pediatric low-grade glioma patients.
Selt F; van Tilburg CM; Bison B; Sievers P; Harting I; Ecker J; Pajtler KW; Sahm F; Bahr A; Simon M; Jones DTW; Well L; Mautner VF; Capper D; Hernáiz Driever P; Gnekow A; Pfister SM; Witt O; Milde T
J Neurooncol; 2020 Sep; 149(3):499-510. PubMed ID: 33026636
[TBL] [Abstract] [Full Text] [Related]
19. Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma.
Manoharan N; Choi J; Chordas C; Zimmerman MA; Scully J; Clymer J; Filbin M; Ullrich NJ; Bandopadhayay P; Chi SN; Yeo KK
J Neurooncol; 2020 Sep; 149(2):253-262. PubMed ID: 32780261
[TBL] [Abstract] [Full Text] [Related]
20. Pilocytic Astrocytoma: A Review of General, Clinical, and Molecular Characteristics.
Salles D; Laviola G; Malinverni ACM; Stávale JN
J Child Neurol; 2020 Oct; 35(12):852-858. PubMed ID: 32691644
[TBL] [Abstract] [Full Text] [Related]
[Next]
